The Melanoma And Skin Cancer Institute (MSCI)

is a medical oncology practice and research institute specializing in treating patients diagnosed with melanoma and other types of skin cancers via in-person and telehealth consultation.  Headquartered in Denver, CO and led by Dr. Ryan Weight, the MSCI offers a combined 20 years of experience caring for cancer patients. Dr. Weight has a reputation for the sincerity and quality of his patient care. A well-known expert in the skin cancer field, Dr. Weight practices on the cutting edge of medicine, having co-authored practice-changing clinical trials in melanoma and providing patients access to life-saving treatments through these and other clinical studies.  Dr. Weight and his team take pride in helping patients and their families understand the disease process in order to make informed decisions that fit their personal goals.  The MSCI accepts major insurances including medicare and medicaid, and works with all patients to ensure that they receive the highest quality care.

Clinical Trials: The MSCI partners with The Sarah Cannon Research Institute to offer clinical trials tailored to melanoma and skin cancer patients including early phase and first-in-human clinical trials.

Community Engagement: The MSCI also partners with the Colorado Melanoma Foundation to provide skin cancer resources to the community through The Sun Bus program.